Hearing Aids May Cut Dementia Risk in Older Adults, Study Finds

Elderly listening

A recent analysis of nearly 3,000 Australians in their mid‑70s reveals that older adults who wear hearing aids face a noticeably lower likelihood of developing dementia.

Who Took Part in the Research?

The investigators followed 2,777 participants who all reported moderate hearing loss but had never used hearing aids before the study began. None of them showed signs of dementia at the start.

During the monitoring period, 664 people received a prescription for hearing aids and reported how often they wore the devices.

How Cognitive Health Was Monitored

Each year for seven years, the cohort completed a battery of tests that measured memory, language, and processing speed. By the study’s end, 117 participants had been diagnosed with dementia.

What the Numbers Showed

When researchers compared the two groups, average scores on the cognitive exams remained virtually identical, suggesting that the aids did not boost test performance.

However, looking at dementia incidence painted a different picture. After adjusting for age, sex, diabetes, heart disease and other health factors, only 5 % of those with hearing aids developed dementia, versus 8 % of those without—a 33 % risk reduction.

Similarly, the proportion of participants who experienced broader cognitive impairment dropped from 42 % in the non‑aid group to 36 % in the aid group, a 15 % relative decrease.

More consistent use of the devices correlated with an even steadier decline in dementia risk.

Implications for Brain Health

Lead researcher Ryan explained that while the study did not detect higher test scores, the association between hearing‑aid use and lower dementia rates hints that maintaining auditory input may help protect the brain.

"The findings suggest that for seniors with hearing loss, wearing aids could be a simple strategy to preserve cognitive function," he said. "Further research is needed to uncover the underlying mechanisms. "

Limitations and Funding

The sample was generally healthy and cognitively strong at baseline, so results might differ for individuals with existing impairment. The work was supported by the U.S. National Institutes of Health, the National Institute on Aging, the Australian government and Monash University.